Urenco has agreed to supply high-assay low-enriched uranium (HALEU) from its UK plant to Swedish reactor developer Blykalla's first project in the United States, the companies announced on Monday, 16 November 2026. The agreement is described as the world's first HALEU supply deal tied to a commercial lead-cooled reactor.
Blykalla's SEALER design
Blykalla plans to build its 55-megawatt small modular Swedish Advanced Lead Reactors (SEALER) in both Sweden and the United States. The company says the Urenco agreement secures future fuel supplies early, giving its deployment programme a clearer path to HALEU before reactors are built.
HALEU has so far only been commercially available from Russia.
UK plant underpins supply
The HALEU will be produced at Urenco's Cheshire site in England, which secured UK government funding in 2024 and expects to produce the fuel from 2031. Britain is investing almost £200 million ($265 million) with Urenco to build Europe's first HALEU production facility. HALEU is enriched to levels of up to 20% U-235, compared with around 5% for the uranium that powers most nuclear plants.
The UK government says the plant will be needed for the next generation of nuclear energy projects. Until now, HALEU has only been commercially available from Russia, a dependence that Western governments and advanced reactor developers are trying to break.
Supply chain signal
Urenco is one of the world's largest uranium enrichment companies and is expanding capacity across sites in Britain, Germany, the Netherlands and the United States. The Blykalla deal adds a commercial lead-cooled reactor developer to its future HALEU customer base, alongside conventional enrichment customers.
For Blykalla, the agreement is a fuel-procurement milestone rather than confirmation that its US project has been licensed, built or is operating. Still, tying a first US project to UK-produced HALEU shows how advanced reactor developers are trying to lock in enrichment capacity years before first power.
This article was assisted by AI analysis. Please refer to the original source for official information.